ICoMI - International Congress of Micro-Immunotherapy 2017

ICoMI 2017: Where Science and Clinical Practice meet… This congress offers a unique opportunity for research scientists, lab technicians and health professionals (physicians, physicians-in-training, students) from all around the world to meet, discuss and interchange experiences in the field of immunomodulation and chronic diseases. - Immunomodulation: a highly promising therapeutic approach Although chronic diseases present a significant challenge, the aim of the ICoMI 2017 Congress is to present all the latest developments in the understanding of the link between autoimmune processes, pathologies and available care options. Immunotherapy in general and, more specifically, types of therapy that use immunocompetent substances in small doses, such as micro-immunotherapy, offer a series of highly promising outlooks.